Health

Intermittent Fasting Shows No Clear Advantage Over Traditional Diets for Weight Loss

A comprehensive new Cochrane review of 22 studies involving nearly 2,000 participants over six months to one year has found that intermittent fasting may offer little to no significant benefit over standard dietary advice for weight loss in people with overweight or obesity. When compared to regular, calorie-restricted diet plans, intermittent fasting—which includes methods like time-restricted eating or alternate-day fasting—resulted in only a minimal difference in weight loss (an average of 0.33% greater loss) and showed no meaningful impact on quality of life or adverse events, though the evidence for the latter two outcomes is uncertain. The review also found that while fasting was somewhat more effective than doing nothing at all, it did not lead to clinically meaningful changes in most health outcomes. The authors conclude that physicians and patients should base the decision to try intermittent fasting on individual practicality and sustainability, rather than an expectation of superior results, noting that more long-term research is needed to understand its effects beyond 12 months. Source: https://www.cochranelibrary.com/

hyangiu

Recent Posts

SGLT2 Inhibitors Tied to Lower Risk in Patients with Diabetes and Cirrhosis

A rigorous cohort study utilizing Taiwan’s National Health Insurance Database provides robust evidence that SGLT2…

13 hours ago

Lobar and Mixed Cerebral Microbleeds Linked to Increased Dementia Risk

A new study investigating the link between cerebral microbleeds (CMBs) and dementia has found that…

4 days ago

DASH Diet Best for Long-Term Brain Health

A comprehensive prospective study tracking over 159,000 adults for up to three decades has provided…

1 week ago

Healthy Dietary Patterns Linked to Better Life Expectancy

A large-scale study involving 103,649 UK Biobank participants has revealed that adhering to healthy dietary…

3 weeks ago

Statin Adverse Effects Analysis: Separating Signal from Noise

To address uncertainties in statin safety profiles, which are often based on observational data susceptible…

3 weeks ago

Early Time-of-Day Immunotherapy Shows Survival Benefit in Lung Cancer Trial

In a Chinese phase 3 trial (LungTIME-C01) involving 210 patients with advanced non-small cell lung…

1 month ago

This website uses cookies.